Obesity drug dosing gets a makeover: acyclovir study aims for precision
NCT ID NCT05589688
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study looks at how to give the right dose of acyclovir to people with obesity. Researchers will measure lean body mass using a special scan to see if it helps predict how the drug is cleared by the kidneys. The study includes 20 healthy volunteers with different body sizes, from normal weight to moderate obesity. The goal is to make dosing safer and more effective for obese patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Toulouse Hospital
RECRUITINGToulouse, France
Contact
Conditions
Explore the condition pages connected to this study.